Translate this page into:
Oxytetracycline in Pyoderma
|How to cite this article:
Sharma A K, Gupta R, Saxena U, Jain R K. Oxytetracycline in Pyoderma. Indian J Dermatol Venereol Leprol 1983;49:118-121
AbstractOne hundred patients with moderate to severe pyoderma were treated with oral oxytetracycline. The most common organism isolated were coagulase positive Staph pyogenes and Str betahemolyticus. Of 100 patients; 87 showed a successful therapeutic response. The predictive value of in vitro test for bacterial susceptibility to oxytetracycline (30 mcg disc) was 88% for "sensitive" reports but 17% for "resistant" reports.Judged by clinical response the incidence of false sensitive reports was 12% (9/87) but that of false resistant reports was 83 (22/26).